The CellKey™384 System enables high throughput screening with a label-free cell based assay platform
8 July 2008
In recent years, the incorporation of cell based assays in the early, high throughput phases of drug discovery has undergone a dramatic increase. As part of this growing trend, label free cell based assays are being adopted at growing rates as they offer many advantages to cellular screening. This poster successfully demonstrates the feasibility of scaling a label free impedance assay to high throughput screening using the CellKey™384 System.